GlassScriptPhysician profile
Karlene Witter
NPI 1740716414
$3,877.88
in general payments reported to CMS, 2019-2025
25 companies · $765 in 2025
The $765 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $58.62 · 2022: $520 · 2023: $1,203 · 2024: $1,331 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,992 · Travel and Lodging: $271 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,991.69 |
| Travel and Lodging | $271.27 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $899.18 | 2021-2025 | Belbuca, Xtampza |
| Boston Scientific Corporation | $638.66 | 2021-2025 | Intracept, General - Therapies, Intracept Rf Probe |
| Medtronic, INC. | $601.59 | 2022-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Abbvie INC. | $475.16 | 2022-2025 | |
| Tersera Therapeutics LLC | $303.47 | 2023-2025 | Prialt |
| Pfizer INC. | $144.88 | 2023-2025 | |
| Vertos Medical, INC. | $101.56 | 2023-2024 | Mild Device Kit |
| Scilex Pharmaceuticals INC. | $98.23 | 2022-2023 | Ztlido |
| Neurometrix INC | $68.32 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $58.53 | 2022-2023 | Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.70 | 2023-2024 | Relistor |
| Vertex Pharmaceuticals Incorporated | $56.29 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $52.62 | 2023-2025 | Xeomin |
| Radius Health, INC. | $47.47 | 2023 | Tymlos |
| Biohaven Pharmaceutical Holding Company LTD. | $42.28 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $42.04 | 2023 | Intracept |
| Lilly USA, LLC | $40.71 | 2022-2024 | Emgality, Reyvow |
| Grt US Holding, INC. | $31.77 | 2022 | |
| Si-Bone, INC. | $23.59 | 2024 | |
| Redhill Biopharma INC. | $18.38 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.15 | 2023 | Quviviq |
| Coastal Medical Technologies LLC | $15.34 | 2024 | |
| Spinal Simplicity, LLC | $14.76 | 2025 | Ha Minuteman G3-R |
| Hikma Pharmaceuticals USA | $14.13 | 2022 | |
| Fidia Pharma USA INC. | $14.07 | 2024 | Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karlene Witter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.